Gene amplification and tumor progression.

[1]  S. Rodenhuis,et al.  Allele‐specific detection of K‐ras oncogene expression in human non‐small‐cell lung carcinomas , 2007, International journal of cancer.

[2]  Thea D. Tlsty,et al.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53 , 1992, Cell.

[3]  G. Wahl,et al.  Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles , 1992, Cell.

[4]  P. Meltzer,et al.  Amplification of a gene encoding a p53-associated protein in human sarcomas , 1992, Nature.

[5]  P. Meltzer,et al.  SAS amplification in soft tissue sarcomas. , 1992, Cancer research.

[6]  Yosef Yarden,et al.  Isolation of the Neu HER-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cells , 1992, Cell.

[7]  T. Tlsty,et al.  Suppression of gene amplification in human cell hybrids. , 1992, Science.

[8]  L. Schnipper,et al.  Oncogenes result in genomic alterations that activate a transcriptionally silent, dominantly selectable reporter gene (neo) , 1992, Molecular and cellular biology.

[9]  S. McKenzie.  Diagnostic utility of oncogenes and their products in human cancer. , 1991, Biochimica et biophysica acta.

[10]  C. Dang.  c-myc oncoprotein function. , 1991, Biochimica et biophysica acta.

[11]  V. Prassolov,et al.  A 25 kDa polypeptide is the ligand for p185neu and is secreted by activated macrophages. , 1991, Oncogene.

[12]  K. Dobashi,et al.  Isolation and characterization of a neu protein-specific activating factor from human ATL-2 cell conditioned medium. , 1991, Biochemical and biophysical research communications.

[13]  J. Stolwijk,et al.  Isolation of two distinct epithelial cell lines from a single feline mammary carcinoma with different tumorigenic potential in nude mice and expressing different levels of epidermal growth factor receptors. , 1991, Cancer research.

[14]  P. Borst,et al.  Multidrug resistance mediated by P-glycoproteins. , 1991, Seminars in cancer biology.

[15]  M. Yu,et al.  Distinction of low grade from high grade human ovarian carcinomas on the basis of losses of heterozygosity on chromosomes 3, 6, and 11 and HER-2/neu gene amplification. , 1991, Cancer research.

[16]  Enrietto Pj,et al.  Cell transformation by the epidermal growth factor receptor and v-erbB. , 1991 .

[17]  A. Balmain,et al.  Progression of squamous carcinoma cells to spindle carcinomas of mouse skin is associated with an imbalance of H-ras alleles on chromosome 7. , 1991, Cancer research.

[18]  M. Carcangiu,et al.  Trisomy 12 and K‐ras‐2 Amplification in human ovarian tumors , 1991, International journal of cancer.

[19]  N. Lemoine,et al.  Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer. , 1991, British Journal of Cancer.

[20]  Brondyk Wh,et al.  N-myc oncogene enhances mitogenic responsiveness of diploid human fibroblasts to growth factors but fails to immortalize. , 1991 .

[21]  M. Kraus,et al.  Oncogenic potential of erbB-2 in human mammary epithelial cells. , 1991, Oncogene.

[22]  N. Hayward,et al.  Analysis of gene amplification in head‐and‐neck squamous‐cell carcinomas , 1991, International journal of cancer.

[23]  M. Cole.  Myc meets its max , 1991, Cell.

[24]  A. Benabid,et al.  Activation of myc gene family in human lung carcinomas and during heterotransplantation into nude mice. , 1991, Cancer research.

[25]  R. Bernards.  N‐myc disrupts protein kinase C‐mediated signal transduction in neuroblastoma. , 1991, The EMBO journal.

[26]  J. Cairns,et al.  Amplification at chromosome 11q13 in transitional cell tumours of the bladder. , 1991, Oncogene.

[27]  C. James,et al.  Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. , 1991, Cancer research.

[28]  M. Imamura,et al.  Deletion of 17p and amplification of the int-2 gene in esophageal carcinomas. , 1991, Cancer research.

[29]  A. Arnold,et al.  A novel cyclin encoded by a bcl1-linked candidate oncogene , 1991, Nature.

[30]  P. Chardin.  Small GTP-binding proteins of the ras family: a conserved functional mechanism? , 1991, Cancer cells.

[31]  P. Fort,et al.  Worldwide migration of amplified insecticide resistance genes in mosquitoes , 1991, Nature.

[32]  B. Dutrillaux,et al.  GST pi gene is frequently coamplified with INT2 and HSTF1 proto-oncogenes in human breast cancers. , 1991, Oncogene.

[33]  Y. Kitagawa,et al.  Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma. , 1991, Cancer research.

[34]  E. Schuuring,et al.  D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. , 1991, Oncogene.

[35]  K. Kinzler,et al.  The zinc finger protein GLI transforms primary cells in cooperation with adenovirus E1A , 1991, Molecular and cellular biology.

[36]  T. Shows,et al.  Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. , 1991, Oncogene.

[37]  T. Perren.  c-erbB-2 oncogene as a prognostic marker in breast cancer. , 1991, British Journal of Cancer.

[38]  C. Marshall.  How does p21ras transform cells? , 1991, Trends in genetics : TIG.

[39]  P. Herrlich,et al.  Retinoic‐acid‐induced differentiation prevents gene amplification in teratocarcinoma stem cells , 1991, International journal of cancer.

[40]  W. McGuire,et al.  Follow-up study of HER-2/neu amplification in primary breast cancer. , 1991, Cancer research.

[41]  R. Fourney,et al.  Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer. , 1991, Cancer research.

[42]  A. Ullrich,et al.  Heterotransplantation of human breast carcinomas in nude mice. Correlation between successful heterotransplants, poor prognosis and amplification of the her‐2/neu oncogene , 1991, International journal of cancer.

[43]  M. Fernö,et al.  Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. , 1991, British Journal of Cancer.

[44]  M. Maltoni,et al.  Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients. , 1990, Cancer research.

[45]  B. Vogelstein,et al.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. , 1990, Cancer research.

[46]  S. Hirohashi,et al.  Heterogenous amplification of myc family oncogenes in small cell lung carcinoma , 1990, Cancer.

[47]  J. Hamlin,et al.  The mammalian dihydrofolate reductase locus. , 1990, Biochimica et biophysica acta.

[48]  M. Ladanyi,et al.  Gene amplification in gastric and esophageal adenocarcinomas. , 1990, Cancer research.

[49]  R. Versteeg,et al.  N-myc expression switched off and class I human leukocyte antigen expression switched on after somatic cell fusion of neuroblastoma cells , 1990, Molecular and cellular biology.

[50]  J. Nesland,et al.  Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis. , 1990, British Journal of Cancer.

[51]  J. Dudley,et al.  Analysis of the int-1, int-2, c-myc, and neu oncogenes in human breast carcinomas. , 1990, Cancer research.

[52]  M. Katsuki,et al.  Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. , 1990, Oncogene.

[53]  M. Schwab,et al.  Augmented MYCN expression advances the malignant phenotype of human neuroblastoma cells: evidence for induction of autocrine growth factor activity. , 1990, Cancer research.

[54]  H. Hameister,et al.  Amplification and rearrangement of c-myc in radiation-induced murine osteosarcomas. , 1990, Cancer research.

[55]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[56]  K. Somers,et al.  Amplification of the int-2 gene in human head and neck squamous cell carcinomas. , 1990, Oncogene.

[57]  J. Pierce,et al.  Transformation of NIH 3T3 cells by overexpression of the normal coding sequence of the rat neu gene , 1990, Molecular and cellular biology.

[58]  S. Garte,et al.  Amplification of the c-myc oncogene during progression of radiation-induced rat skin tumors. , 1990, Cancer research.

[59]  A. Look,et al.  Oncogene amplification in pediatric brain tumors. , 1990, Cancer research.

[60]  G. Peters,et al.  Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer. , 1990, European journal of cancer.

[61]  M. Stanley,et al.  Alterations in growth properties of human papilloma virus type 16 immortalised human cervical keratinocyte cell line correlate with amplification and overexpression of c-myc oncogene. , 1990, Oncogene.

[62]  C. Garrett,et al.  Protooncogene amplification and tumor ploidy in human ovarian neoplasms. , 1990, Human pathology.

[63]  T. Iwama,et al.  Transforming genes from familial adenomatous polyposis patient cells detected by a tumorigenicity assay. , 1990, Oncogene.

[64]  B. Korf,et al.  myc gene amplification and expression in primary human neuroblastoma. , 1990, Cancer research.

[65]  N. Lemoine,et al.  Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer. , 1990, Oncogene.

[66]  L. Penn,et al.  C-MYC: evidence for multiple regulatory functions. , 1990, Seminars in cancer biology.

[67]  T. Yagi,et al.  Induction of a variety of tumors by c‐erbB2 and clonal nature of lymphomas even with the mutated gene (Val659‐‐‐‐Glu659). , 1990, The EMBO journal.

[68]  G. Hortobagyi,et al.  c-erbB-2 amplification in node-negative human breast cancer. , 1989, Cancer research.

[69]  M. Israel,et al.  Expression of class I histocompatibility antigens in neuroectodermal tumors is independent of the expression of a transfected neuroblastoma myc gene. , 1989, Journal of immunology.

[70]  Y. Assaraf,et al.  The pattern of dihydrofolate reductase expression through the cell cycle in rodent and human cultured cells. , 1989, The Journal of biological chemistry.

[71]  M. Noguchi,et al.  Amplification of protooncogenes in surgical specimens of human lung carcinomas. , 1989, Cancer research.

[72]  H. Rabes,et al.  Amplification, rearrangements, and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro. , 1989, Cancer research.

[73]  M. Aapro,et al.  Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas. , 1989, Cancer research.

[74]  Y. Shiloh,et al.  Amplification of c‐myc and c‐erbB‐2 proto‐oncogenes in human solid tumors: Frequency and clinical significance , 1989, International journal of cancer.

[75]  V. Combaret,et al.  Clinical value of N-myc oncogene amplification in 52 patients with neuroblastoma included in recent therapeutic protocols. , 1989, European journal of cancer & clinical oncology.

[76]  C. Theillet,et al.  Proto-oncogene amplification and human breast tumor phenotype. , 1989, Oncogene.

[77]  A. Rustgi,et al.  Suppression of MHC class I gene expression by N‐myc through enhancer inactivation. , 1989, The EMBO journal.

[78]  R. Callahan,et al.  Amplification of the proto-oncogenes int-2, c-erb B-2 and c-myc in human breast cancer. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[79]  T. Sugimura,et al.  High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas. , 1989, Cancer research.

[80]  G. Merlo,et al.  Expression of int-2 mRNA in human tumors amplified at the int-2 locus. , 1989, Oncogene.

[81]  P. Quirke,et al.  c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma. , 1989, British Journal of Cancer.

[82]  I. Pastan,et al.  Expression of a human multidrug resistance gene in ovarian carcinomas. , 1989, Cancer research.

[83]  J. Yang,et al.  Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. , 1989, Oncogene.

[84]  T. Frebourg,et al.  The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review). , 1989, Anticancer research.

[85]  J. Osinga,et al.  Amplification and expression of different myc‐family genes in a tumor specimen and 3 cell lines derived from one small‐cell lung cancer patient during longitudinal follow‐up , 1989, International journal of cancer.

[86]  D. Birnbaum,et al.  Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas. , 1989, Oncogene.

[87]  G. Wahl,et al.  Recent progress in understanding mechanisms of mammalian DNA amplification , 1989, Cell.

[88]  S. Hirohashi,et al.  Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1. , 1989, Cancer research.

[89]  R. Ueda,et al.  Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics. , 1989, Cancer research.

[90]  G. Klein,et al.  Oncogene Amplification in Squamous Cell Carcinoma of the Oral Cavity , 1989, Japanese journal of cancer research : Gann.

[91]  D. Miller,et al.  Mouse fibroblasts transformed with the human c-myc gene express a high level of mRNA but a low level of c-myc protein and are non-tumorigenic in nude mice. , 1989, Oncogene.

[92]  K. Asano,et al.  Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck. , 1989, British Journal of Cancer.

[93]  M. Friedlander,et al.  Amplification of c‐ras‐ki oncogene in human ovarian tumours , 1989, International journal of cancer.

[94]  D. Horsfall,et al.  The significance of oncogene amplification in primary breast cancer , 1989, International journal of cancer.

[95]  M. Mathieu,et al.  Structure and expression of c‐erbB‐2 and EGF receptor genes in inflammatory and non‐inflammatory breast cancer: Prognostic significance , 1989, International journal of cancer.

[96]  M. Kraus,et al.  Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases. , 1989, Oncogene.

[97]  I. Pastan,et al.  Expression of Multidrug Resistance Gene in Human Cancers , 1989 .

[98]  M. Noguchi,et al.  myc family gene abnormality in lung cancers and its relation to xenotransplantability. , 1988, Cancer research.

[99]  J. Rossi,et al.  Detection of drug resistance in human tumors by in vitro enzymatic amplification. , 1988, Cancer research.

[100]  M. Schwab,et al.  Tumorigenicity of SEWA murine cells correlates with degree of c-myc amplification. , 1988, Oncogene.

[101]  R. Makuch,et al.  myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines. , 1988, Cancer research.

[102]  B. Sefton.  neus about c-erb-B-2 and HER2. , 1988, Trends in genetics : TIG.

[103]  K. Sugio,et al.  Differential expression of c-myc gene and c-fos gene in premalignant and malignant tissues from patients with familial polyposis coli. , 1988, Cancer research.

[104]  R. Cassingena,et al.  High c-myc amplification level contributes to the tumorigenic phenotype of the human breast carcinoma cell line SW 613-S. , 1988, Oncogene.

[105]  R. Lidereau,et al.  Genetic variability of proto-oncogenes for breast cancer risk and prognosis. , 1988, Biochimie.

[106]  J. Yokota,et al.  Heterogeneity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes. , 1988, Oncogene.

[107]  E. Sausville,et al.  L-myc cooperates with ras to transform primary rat embryo fibroblasts , 1988, Molecular and cellular biology.

[108]  A. Kaye,et al.  Selective amplification of the cytoplasmic domain of the epidermal growth factor receptor gene in glioblastoma multiforme. , 1988, Cancer research.

[109]  D. Birnbaum,et al.  Chromosomal localization of the hst oncogene and its co-amplification with the int.2 oncogene in a human melanoma. , 1988, Oncogene.

[110]  A. Levinson,et al.  High-level expression of c-H-ras1 fails to fully transform rat-1 cells , 1988, Molecular and cellular biology.

[111]  R. Versteeg,et al.  c‐myc down‐regulates class I HLA expression in human melanomas. , 1988, The EMBO journal.

[112]  M. Shibuya,et al.  Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors , 1988, Molecular and cellular biology.

[113]  B. Groner,et al.  Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. , 1988, Cancer research.

[114]  J. Maisin,et al.  Provirus integration and myc amplification in 90Sr induced osteosarcomas of CF1 mice. , 1988, Oncogene.

[115]  G. Casey,et al.  Amplification of human int-2 in breast cancers and squamous carcinomas. , 1988, Oncogene.

[116]  G. Peters,et al.  Amplification of the int-2 gene in primary human breast tumors. , 1988, Oncogene research.

[117]  J. L. Bos,et al.  ras oncogene activation in human ovarian carcinoma. , 1988, Oncogene.

[118]  J. Mattison,et al.  Expression and biosynthetic variation of the epidermal growth factor receptor in human hepatocellular carcinoma-derived cell lines , 1988, Molecular and cellular biology.

[119]  A. Ullrich,et al.  Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells , 1987, Cell.

[120]  I. Pastan,et al.  Epidermal-growth-factor-dependent transformation by a human EGF receptor proto-oncogene. , 1987, Science.

[121]  G. Bepler,et al.  Amplification and expression of protooncogenes in human small cell lung cancer cell lines. , 1987, Cancer research.

[122]  M. Cole,et al.  Immortalization by c-myc, H-ras, and Ela oncogenes induces differential cellular gene expression and growth factor responses , 1987, Molecular and cellular biology.

[123]  C R King,et al.  erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. , 1987, Science.

[124]  M. J. van de Vijver,et al.  Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene , 1987, Molecular and cellular biology.

[125]  G. Riou,et al.  C-myc PROTO-ONCOGENE EXPRESSION AND PROGNOSIS IN EARLY CARCINOMA OF THE UTERINE CERVIX , 1987, The Lancet.

[126]  J. Trent,et al.  Identification of an amplified, highly expressed gene in a human glioma. , 1987, Science.

[127]  R. Palmiter,et al.  Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice , 1987, Cell.

[128]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[129]  J. Trent,et al.  Epidermal growth factor receptor gene-amplified MDA-468 breast cancer cell line and its nonamplified variants , 1987, Molecular and cellular biology.

[130]  R. Weinberg,et al.  N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma , 1986, Cell.

[131]  C. Cooper,et al.  Amplification and overexpression of the met gene in spontaneously transformed NIH3T3 mouse fibroblasts. , 1986, The EMBO journal.

[132]  F. Dautry,et al.  Growth stimulation of rat primary embryo fibroblasts by the human myc gene. , 1986, Experimental cell research.

[133]  C. Marshall,et al.  Transformation and stimulation of DNA synthesis in NIH‐3T3 cells are a titratable function of normal p21N‐ras expression. , 1986, The EMBO journal.

[134]  J. B. Santon,et al.  Effects of epidermal growth factor receptor concentration on tumorigenicity of A431 cells in nude mice. , 1986, Cancer research.

[135]  A. Balmain,et al.  v-ras genes from harvey and BALB murine sarcoma viruses can act as initiators of two-stage mouse skin carcinogenesis , 1986, Cell.

[136]  A. Balmain,et al.  Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis , 1986, Nature.

[137]  E. Winter,et al.  Oncogene amplification during tumorigenesis of established rat fibroblasts reversibly transformed by activated human ras oncogenes , 1986, Molecular and cellular biology.

[138]  Cori Bargmann,et al.  Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185 , 1986, Cell.

[139]  R. Weinberg,et al.  Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts , 1986, Molecular and cellular biology.

[140]  O. Hyrien,et al.  Segregation and rearrangement of coamplified genes in different lineages of mutant cells that overproduce adenylate deaminase , 1986, Molecular and cellular biology.

[141]  J. Yokota,et al.  Alterations of myc, myb, and rasHa proto-oncogenes in cancers are frequent and show clinical correlation. , 1986, Science.

[142]  H. Varmus,et al.  Augmented expression of normal c-myc is sufficient for cotransformation of rat embryo cells with a mutant ras gene , 1985, Molecular and cellular biology.

[143]  J. Griffith.  Coordinate expression of amplified metallothionein I and II genes in cadmium-resistant Chinese hamster cells , 1985, Molecular and cellular biology.

[144]  J. Battey,et al.  L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer , 1985, Nature.

[145]  H. Sather,et al.  Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. , 1985, The New England journal of medicine.

[146]  M. Barbacid,et al.  ras gene Amplification and malignant transformation , 1985, Molecular and cellular biology.

[147]  L. Johnson,et al.  Control of thymidylate synthase mRNA content and gene transcription in an overproducing mouse cell line , 1985, Molecular and cellular biology.

[148]  L. Augenlicht,et al.  Amplification and elevated expression of c-myc in a chemically induced mouse colon tumor. , 1985, Cancer research.

[149]  M. Poupon,et al.  Increased level of amplification of the c-myc oncogene in tumors induced in nude mice by a human breast carcinoma cell line. , 1985, Cancer research.

[150]  H. Varmus,et al.  Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture , 1985, Nature.

[151]  V. Ling,et al.  Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[152]  Hermona Soreq,et al.  Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin , 1985, Nature.

[153]  F. Alt,et al.  Activated expression of the N-myc gene in human neuroblastomas and related tumors. , 1984, Science.

[154]  D. Spandidos,et al.  Malignant transformation of early passage rodent cells by a single mutated human oncogene , 1984, Nature.

[155]  R. Schimke.  Gene amplification in cultured animal cells , 1984, Cell.

[156]  H. Varmus,et al.  Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. , 1984, Science.

[157]  G. Peters,et al.  Tumorigenesis by mouse mammary tumor virus: Proviral activation of a cellular gene in the common integration region int-2 , 1984, Cell.

[158]  R T Schimke,et al.  Gene amplification, drug resistance, and cancer. , 1984, Cancer research.

[159]  J. Mendelsohn,et al.  Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies. , 1984, Cancer research.

[160]  F. Alt,et al.  Transposition and amplification of oncogene-related sequences in human neuroblastomas , 1983, Cell.

[161]  J. Trent,et al.  Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour , 1983, Nature.

[162]  P. Reitsma,et al.  Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite , 1983, Nature.

[163]  J. Minna,et al.  Amplification and expression of the c-myc oncogene in human lung cancer cell lines , 1983, Nature.

[164]  M. Brown,et al.  Amplification of the gene for 3-hydroxy-3-methylglutaryl coenzyme A reductase, but not for the 53-kDa protein, in UT-1 cells. , 1983, The Journal of biological chemistry.

[165]  J. Minna,et al.  Unstable methotrexate resistance in human small-cell carcinoma associated with double minute chromosomes. , 1983, The New England journal of medicine.

[166]  D. Lowy,et al.  Tumorigenic transformation of mammalian cells induced by a normal human gene homologous to the oncogene of Harvey murine sarcoma virus , 1982, Nature.

[167]  G. Stark,et al.  General method for cloning amplified DNA by differential screening with genomic probes , 1982, Molecular and cellular biology.

[168]  L. Augenlicht,et al.  Aggressive subtypes of human colorectal tumors frequently exhibit amplification of the c-myc gene. , 1991, Oncogene.

[169]  J. Bourhis,et al.  Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma. , 1991, Progress in clinical and biological research.

[170]  M. Fernö,et al.  ERBB2 amplification in breast cancer with a high rate of proliferation. , 1991, Oncogene.

[171]  F. Alt,et al.  myc family oncogenes in the development of normal and neoplastic cells. , 1991, Advances in cancer research.

[172]  P. Vogt,et al.  jun: oncogene and transcription factor. , 1990, Advances in cancer research.

[173]  D. Birnbaum,et al.  BCL-1 participates in the 11q13 amplification found in breast cancer. , 1990, Oncogene.

[174]  R. Zeillinger,et al.  HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer. , 1989, Oncogene.

[175]  M. Cline,et al.  Proto-oncogene abnormalities in human breast cancer: c-ERBB-2 amplification does not correlate with recurrence of disease. , 1989, Oncogene.

[176]  V. Sorrentino,et al.  Spontaneous or carcinogen-mediated amplification of a mutated ras gene promotes neoplastic transformation. , 1988, Oncogene research.

[177]  J. Feunteun,et al.  cis activation of the c-myc gene in bovine papilloma virus type 1/human c-myc hybrid plasmids. , 1988, Experimental cell research.

[178]  G. Riou,et al.  Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis. , 1988, Oncogene research.

[179]  W. J. Brammar,et al.  Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis. , 1987, Oncogene.

[180]  N. Nomura,et al.  High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. , 1986, Cancer research.

[181]  J. Bertino,et al.  Clinical aspects of drug resistance. , 1986, Cancer surveys.

[182]  M. Cole.  The myc oncogene: its role in transformation and differentiation. , 1986, Annual review of genetics.

[183]  U. Siebenlist,et al.  The regulation and expression of c-myc in normal and malignant cells. , 1986, Annual review of immunology.

[184]  Stark Gr.  DNA amplification in drug resistant cells and in tumours. , 1986 .

[185]  M. Schwab,et al.  Oncogene amplification in tumor cells. , 1986, Advances in cancer research.

[186]  M. Israel,et al.  Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma , 1985, Nature.

[187]  F. Kafatos,et al.  Developmetally regulated gene amplification , 1985 .

[188]  J. Milbrandt,et al.  DNA sequence amplification in mammalian cells. , 1984, International review of cytology.

[189]  J. Trent,et al.  Cytologic evidence for gene amplification in methotrexate-resistant cells obtained from a patient with ovarian adenocarcinoma. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[190]  J. Schornagel,et al.  Resistance to methotrexate due to gene amplification in a patient with acute leukemia. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[191]  R. Schimke,et al.  Gene amplification in a leukemic patient treated with methotrexate. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.